Trial Profile
A longitudinal, prospective trial assessing prevalence of pneumococcal colonization and acquisition rate in South African young children receiving PCV7.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Aug 2023
Price :
$35
*
At a glance
- Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumonia
- Focus Therapeutic Use
- 30 Dec 2015 New trial record